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• Meletonln, Pineal HormoneWlth Antloxldant a 
Property, Protects Against Adrlsmycln 
Cardlomyopsthy In Rats 
I. Morlshlmn, Y, Tekt, K. Okumura, T. ito. Internal Medicine II, Nagoy,'t 
Unlversl~ Nttgoy,'t, Japan 
B~tckgmund: The clinical use of adrlamynin (ADR) is limited by its cardlofox. 
ICily In which free radicals and lipid peroxldaflon m~y be involved, Melatonln 
(MEL) has gained Increasing interest aa a strong antloxldsnt. Accordingly, 
the protective effects of MEL ~galnst ADR cardiomyopathy was evaluated. 
Method: Male Sprague.Dawley r~t~ were divided Into 4 gro~,=p~ as follows: 
ADR (ADR treated, cumulative dose 15 mg/kg bw, Ip, for 2 weeks), MEL 
(MEL treated, cumulative dose 84 mglkg bw, Ip), MEL + ADR (MEL + ADR 
treated), and CeNT (control), After 3 weeks of post treatment observation. 
their cardiac perferman0e w{la assessed, and th(~lr lloarts worn used to 
study myocardial lipid pcroxtd~tion by measuring thiobarblturtc acid reactive 
~ubstance (TBARS) along wttl~ ultrastructuro, 
Results: MEL rovemea the ADR induced cl~nnflo~ in myocardial ultra- 
structure aa well as parameters hown below, 
CeNT ADR MEL MEL + AOR 
HW/E]W ratio 2,03 L 005 2,30 ~ 0,05" 261 t: 0,06 2,71 L 0,05 
A@clt@s (mr) 0 31,7 ~ 03" 0 3;~ ~ 22 
~9P (mmH~]) 124.4 t 2.6 t07.4 L 41' 1~63 t 3.9 124.1 t 32 
FS (%) 508 t 1,t 30.4 t: ~3"  53,4 ! 1 6 500, :* 1 1 
Mortrdity t%) 0 23" 0 0 
TBARS(nmol/gho~rt) 51 3 t 1 1 638 t ~;~" 45 9 ~ 1 6 51 4 t 20 
Datt~ are mann ~ SEM. "p  • 001, "p , 00S vs ~11 oth~tr groups HW/BW: Hnnrt 
woighUbody woIght, SaP: Systolic blood Pro,~sUro, FS: Fr,~cti~n~t shortening 
Conclusion: MEL may be highly effective In protecting against ADR car- 
diomyopathy by pmventin 9 lipid parexidation. 
• Tumor Necrosis Factor-~ Induces Contract i le 
Dysfunction In Conjunct ion With Nitric Oxide 
Production In Conscious Dogs 
D.R, Murray, B. Chandrasekar, G,L, Freeman. Medicine/Cardiology The 
Univemit), at Texas Health Science Center, and ALMMVH, Sat) Antonio, TX 
7'8284.7874, USA 
Tumor necrosis lacier (TNF).(Y promotes elaboration of the inducible iso- 
torm of NO synlhase fiNeS); however, the relationship between subsequent 
NO prodactton and the development of contractile dysfunction in vi~,., is not 
known. Accordingly, six chronically instrumented, conscious dogs pretreated 
with propranolol (2 mg/kg) and atropine (2 rag) were studied before and 
after 1 hour infusion of TNF.~, (40 ;~g/kg). LV contractility was determined 
by end-systolic elastanco, Eos 1,ram Hgtml). and plasma nitrite + nitrate 
levels (NO~ +NO~; t~M) by vanadium roauctton, Dogs wore killed 24 hour 
after TNF-t~ or saline; hearts were frozen and assessed for iNOS protein 
levels (Western blotting), iNOS enzyme activity (conversion of ~H-arginine 
to 3H-citru!line in the presence of EGTA+EDTA), localization of iNOS (im- 
munohistochemistry, IHC). and NF-~ B. a transcription factor involved in the 
upregulation of iNOS (etectr,~phoretiC mobility shift assay). In TNF-(r treated 
dogs. we observed a 4-fold increase in NF-,B levels, a 3-laid increase in 
myocardial iNOS protein, and an 18*fold increase in enzymatic activity (P ... 
0,001 for each). IHC localized iNOS predominantly to vascular endothelium 
and smooth muscle and less intensely to cardiomyocytes. 
Pm-TNF-~v 1 h posl 7 h post 24 h pc'c~ 
Ees 5.4 ~ 04 79 ~ 1 4' 5.2 ~ 05 32 ~ 04' 
NO;~ +NO;) 17.6 ± ~.5 14.7 ± 1 4 18.6 ~. 1.8 38.5 t 64' 
'P ~ 0 05Vscorrespondingpre-TNF-, 
We Conclude: TNF-¢t administration upregulates functionally active iNOS 
in the heart, possibly through activation of NF., B, Increased Plasma metabo- 
tiles of NO stror, gly correlate with ;a viva cardiac depression after TNF-~. 
• Positive Inotroplc Effect of Bradyklnln: Role of 
Cardiac Endothellum, Nitric Oxide, 
Prostaglandlne and Endothelln 
P, Mohan, D,L, Brutsaort, S,U, Sys, Untverstty of Antwerp, Antwerp, Belgium 
Background: Bradyklnln (Brad) causes endethelium-dependent vascular 
smooth muscle relaxation and may explain some of the beneficial cardiac 
effects of angtotensln converting enzyme inhibitor therapy, grad recoptom 
are also present on cardiomyocytes, However, the Inotmplc effect of Brad 
on myocardlum, In particular role of endocardlat endothellum fEE), media. 
tom released by EE.nltrlc oxide (NO), pmstnglandlns (PG) ~nd endothnlln, 
rind Interaction with concomitant/hadrenerglc stimulation have not been 
investigated, 
Methods: Wc examined myocardial effects of Brad (10 °M to 10 s M) in 
isolated Cat papillary muscles (Krobs-Rlnger 1,25 mM Ca" .  35oC, enalsprilat: 
5 x 10 ~ M, nfenotol: 2 x 10 ~ M) before (+EE: n = 7) and aftQr selective 
damage of EE (-EE: n = 7: ls immersion in Trlton.X, 0,5%), To investigate 
role of NO, PG sad ondotheltn, Br~d was also added in subgroups of *EE 
muscles incubated with L-NA (3 ~. 10 ~ M, n ~ 8), indomethacin (INDO: 10 ~ 
M, n ..= 8) or 90123 (10 " M, n = 7) respectively, 
Results: (mean t SE, A% baseline) In .EE, Brad induceq an dose. 
dcpendent increase in peak aotivo tension (AT'. 10 ~ M =. 93 :t: 3,1) with no 
change in time to hall relaxation (0.7 t 1 4), This response was blocked by 
the brndykinin recoptc~r antagonist (HOE 140; 10 7 M, n = 3) and was absent 
in .EE, The inotropto response to grad was not inhibited by LNA, INDO or 
BQf23 alone but wa~, inhibited by LNA + INDO (Brad: 10 ~ M; AT = 1.0 -,: 
1.6). Isepretoronol 1,3 . 10 " M).inducod increase tn AT 1,14,4 , 2.0) was 
abollshod by I~md (10 s M) (0.2 t 4.2), which was not modified by LNA + 
tNDO (Q,3 :t~ 4.3), 
Conclusion: Brad induced a cardiac endothalium-dependent positive in- 
otmplc myocardial effect with no effect on relaxation, which was mediated 
by both NO and PG. Brad abolished the effect of concomitant/~.adrenergic 
stimulation, independent of NO and PG. 
• Atrial Natdumtlc Peptlde Decreases Contracti l ity 
end Intracellular pH In Adult Ventrlculsr Myocytes 
M. Tajimo. J, Badunok. BH. Lor~tl. B. Israel. Deaconess Medical Center 
and Harvard Medical School Boston. MA. USA 
Atdal natnuretic peptide (ANP)-cGMP signaling modifies cardiac function by 
natnuresis and vasodilaUon but inotropic effects are controverSial. We stud- 
ied effects of ANP on cell shortening and infracellular signaling in HEPES- 
buffered adult ventricular mt myocytes (n = 26) paced at 0,5 Hz. At baseline 
(B). fractional cell shortening (FS) was 7.9 i 0.2% and intracellular pH (pHi, 
SNARF-1) was 6.92 z~- 0.05. ANP caused a dose-dependent depression el 
contractility (Fig. 1 ). associated with intraeellular acidilicaticJn (Fig. 2). In cells 
loaded with Flue-3 ~, ~ = 5). ANP caused no change in systolic [Ca `~" ]L 
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Summary., ANP directly depresses contractility via intracellular acidilica- 
lion and decreases myofilament [Ca ~*] sensitivity. Similar to negative in- 
otropi~; action of nitric oxide, this may be related to cGMP-mediated disabling 
of forward Na*-H" exchange. 
• Pharmacoklnetlcs of  Agent  Distr ibution From the 
Perlcardial Space: Effects of  Agent  Size and 
Validation of a Mathematical Model for Epicardial 
Penetration 
S,H. Baek. t r,-F. Stall. A. Szabo, LK. Keefer, J. Hrabie, K.L, March. indiana 
University Medical Center, Indianapolis. IN. National Institute of Health. 
Bethesda and Frederick. MD. USA 
Recent data have demonstrated reduction of restenosis in the porcine mod,~l 
by intrapericardial delivery of diazeniumdiolated albumin (NONO-AIb). The 
bioactivity of intrapericardial agents will be importantly modulated by their 
residence time as well as penetration into epicardial tissue. We thus evalu- 
ated the dependence of residence halt-life (RHL) on molecular weight (MW) 
